Schwab Charles CORP Form 4 insider transactions

Director Carolyn Schwab-Pomerantz exercised stock options and sold shares of Charles Schwab Corp on April 22, 2025.

Director Frank Herringer reports exercising stock options and selling shares of Charles Schwab Corp.

Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) common stock on April 3, 2025, under a pre-arranged 10b5-1 trading plan.

Director Marianne Catherine Brown acquired 483 Restricted Stock Units (RSUs) in Schwab Charles Corp on April 1, 2025, as part of the Directors' Deferred Compensation Plan II.

Director Stephen A. Ellis acquired 435 Restricted Stock Units (RSUs) of Charles Schwab Corp on April 1, 2025, under the Directors' Deferred Compensation Plan II.

Director Frank Herringer acquired stock options and restricted stock units in The Charles Schwab Corporation in lieu of cash compensation.

Charles A. Ruffel, a director of Charles Schwab Corp, acquired 1,567 nonqualified stock options on April 1, 2025, under the Directors' Deferred Compensation Plan II.

Paul Woolway, MD, Chief Banking Officer of Schwab, sold shares of common stock on April 1, 2025, under a pre-arranged 10b5-1 trading plan.

Todd M Ricketts, a director at Charles Schwab Corp, reported a transaction involving common stock on March 31, 2025.

Paul Woolway, MD, Chief Banking Officer of Charles Schwab Corp, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Charles Ruffel, a director at Charles Schwab Corp, exercised stock options and acquired shares on March 14, 2025.

Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) common stock on March 6, 2025, under a pre-arranged 10b5-1 trading plan.

Jonathan M. Craig, MD, Head of Investor Services at Charles Schwab Corp, sold 23,258 shares of common stock on March 6, 2025, under a pre-arranged 10b5-1 trading plan.

Paul Woolway, MD, Chief Banking Officer of Charles Schwab Corp, sold 9,887 shares of common stock at an average price of $75.3771 on March 5, 2025, under a pre-arranged 10b5-1 trading plan.

Nigel Murtagh, Chief Risk Officer of Charles Schwab Corp, sold 15,229 shares of common stock on March 5, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Michael Verdeschi, CFO of Charles Schwab Corp, reports the acquisition of 79,344 nonqualified stock options.

Jonathan Beatty, MD, Head of Advisor Services at Charles Schwab Corp, reports acquisition and disposal of company stock and stock options.

Nigel Murtagh, Chief Risk Officer of Charles Schwab Corp, reports acquisition of shares through vesting of restricted stock units and disposition of shares to cover tax obligations.

Jonathan M. Craig, MD, Head of Investor Services at Charles Schwab Corp, reports acquisition and disposal of company stock and derivative securities.

Paul Woolway, MD, Chief Banking Officer at Charles Schwab Corp, reports acquisition and disposal of company stock, including vesting of restricted stock units and sales under a 10b5-1 trading plan.

Richard A. Wurster, a President at Charles Schwab Corp, reported the acquisition and disposal of company stock and derivative securities.

Walter Bettinger, Co-Chairman of Charles Schwab Corp, reports acquisition of shares through vesting of restricted stock units and disposition of shares to cover tax obligations.

General Counsel Peter J. Morgan III reports acquisition of shares through vesting of restricted stock units and disposition of shares to cover tax obligations, along with option grants.

Charles Schwab reports acquisition and disposal of common stock and derivative securities following vesting of performance-based restricted stock units.

Charles Schwab, Co-Chairman of Charles Schwab Corp, reported the sale of 55,598 shares of common stock and a transfer of shares between trusts.

Charles Schwab, Co-Chairman of Charles Schwab Corp, reported selling shares of common stock and transferring shares as gifts, according to a recent SEC filing.

Charles Schwab, Co-Chairman of Charles Schwab Corp, sold shares of the company's common stock on February 18th and 19th, 2025.

Charles Schwab, Co-Chairman of Charles Schwab Corp, exercised stock options and sold shares on February 12th and 13th, 2025.

Walter Bettinger, Co-Chairman of Schwab, exercised stock options and sold a significant number of shares on February 12, 2025.

Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) on February 6, 2025, under a pre-arranged 10b5-1 trading plan.